KDM3B: Difference between revisions
CSV import |
CSV import |
||
| Line 43: | Line 43: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 16:08, 17 March 2025
KDM3B (also known as Lysine Demethylase 3B) is a protein that in humans is encoded by the KDM3B gene. This protein is a member of the Jumonji domain-containing protein family and functions as a histone demethylase, specifically demethylating histone H3 at lysine 9 (H3K9).
Function[edit]
KDM3B is a histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone modification. KDM3B plays a key role in gene expression, cell cycle regulation, and DNA damage response. It is also involved in the embryonic development and is essential for cell differentiation.
Clinical Significance[edit]
Mutations in the KDM3B gene have been associated with various diseases, including cancer. In particular, overexpression of KDM3B has been observed in several types of cancer, including breast cancer, prostate cancer, and lung cancer. This overexpression is thought to contribute to cancer progression by promoting cell proliferation and inhibiting cell differentiation.
Research[edit]
Research into KDM3B is ongoing, with studies focusing on its role in cancer progression and potential as a therapeutic target. In addition, research is being conducted to better understand the role of KDM3B in embryonic development and cell differentiation.
See Also[edit]
- Histone demethylase
- Jumonji domain-containing protein
- Histone modification
- Gene expression
- Cell cycle
- DNA damage
- Embryonic development
- Cell differentiation
- Cancer
References[edit]
<references />
| Genes on human chromosome 5 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This human genetics related article is a stub.
|
| Histone-modifying enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Histone-modifying enzymes related article is a stub.
|
